The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction
Open accessAbstract
Mitochondrial dysfunction is one of the major intracellular lesions of Alzheimer's disease (AD). However, the causative factors involved in the mitochondrial dysfunction in human AD are not well understood. Here we report that nonglycosylated full-length and C-terminal truncated amyloid precursor protein (APP) accumulates exclusively in the protein import channels of mitochondria of human AD brains but not in age-matched controls. Furthermore, in AD brains, mitochondrially associated APP formed stable approximately 480 kDa complexes with the translocase of the outer mitochondrial membrane 40 (TOM40) import channel and a super complex of approximately 620 kDa with both mitochondrial TOM40 and the translocase of the inner mitochondrial membrane 23 (TIM23) import channel TIM23 in an "N(in mitochondria)-C(out cytoplasm)" orientation. Accumulation of APP across mitochondrial import channels, which varied with the severity of AD, inhibited the entry of nuclear-encoded cytochrome c oxidase subunits IV and Vb proteins, which was associated with decreased cytochrome c oxidase activity and increased levels of H2O2. Regional distribution of mitochondrial APP showed higher levels in AD-vulnerable brain regions, such as the frontal cortex, hippocampus, and amygdala. Mitochondrial accumulation of APP was also observed in the cholinergic, dopaminergic, GABAergic, and glutamatergic neuronal types in the category III AD brains. The levels of translocationally arrested mitochondrial APP directly correlated with mitochondrial dysfunction. Moreover, apolipoprotein genotype analysis revealed that AD subjects with the E3/E4 alleles had the highest content of mitochondrial APP. Collectively, these results suggest that abnormal accumulation of APP across mitochondrial import channels, causing mitochondrial dysfunction, is a hallmark of human AD pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“accumulating data certainly do suggest APP and Aβ, as well as the entire γ-secretase complex, physically associate with mitochondria and can effect changes in mitochondrial function [58-67].”
From The Alzheimer’s disease mitochondrial cascade hypothesis: progress and perspectives (2014) · cites this paper as [63]
In the citing paper
“APP blocked mitochondrial import machinery and impaired mitochondrial function in AD brain by forming a complex with translocases of the inner and outer mitochondrial membranes.204”
From Amyloid β-based therapy for Alzheimer’s disease: Challenges, successes and future (2023) · cites this paper as [204]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form
Schägger, H., & von JAGOW, G. (1991) · Analytical Biochemistry · doi:10.1016/0003-2697(91)90094-a · Cited by 2,267
The cholinergic hypothesis of Alzheimer’s disease: A review of progress
Francis, P. T., Palmer, A. M., Snape, M., & Wilcock, G. K. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.2.137 · Cited by 2,198 · cited 1×
“In addition to cholinergic neurons, several other neuronal types, such as dopaminergic, GABAergic, and glutamatergic neurons, have been shown to be affected in the later stages of the pathogenesis of AD (Francis et al., 1999; Francis, 2003).”
BackgroundCopper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120
HYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542
Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447
Mitochondrial abnormalities in Alzheimer's disease
Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367
Translating cell biology into therapeutic advances in Alzheimer's disease
Selkoe, D. J. (1999) · Nature · doi:10.1038/399a023 · Cited by 1,166
Manczak, M., Anekonda, T. S., Henson, E., Park, B. S., Quinn, J., & Reddy, P. H. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl066 · Cited by 1,104
Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease
(1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00057-2 · Cited by 981
Flagged first, then by citations
Research works printed but not linked: 2
- Dasso M (1998) in Current protocols in cell biology, In vitro reconstitution, eds Bonifacino JS Dasso M Harford JB Lippincot-Schawartz J Yamada KM (Wiley, New York), pp 11.0.1–11.0.2.
- Jagannatha Rao, 1999, Trace elements in the cerebrospinal fluid of Alzheimer’s disease, Alzheimers Rep, 2, 333
Cited by
Sorted by citations
Items 401–500 of 790
Lyall, D. M., Royle, N. A., Harris, S. E., Bastin, M. E., Maniega, S. M., Murray, C. L., Lutz, M. W., Saunders, A. M., Roses, A. D., Hernández, M. C. D. V., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080513 · Cited by 37
Mitochondrial accumulation of amyloid β (Aβ) peptides requires TOMM22 as a main Aβ receptor in yeast
Hu, W., Wang, Z., & Zheng, H. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002713 · Cited by 38
Prendecki, M., Florczak‐Wyspianska, J., Kowalska, M., Ilkowski, J., Grzelak, T., Bialas, K., Wiszniewska, M., Kozubski, W. P., & Dorszewska, J. (2018) · Oncotarget · doi:10.18632/oncotarget.26184 · Cited by 38
Talebi, M., Kakouri, E., Talebi, M., Tarantilis, P. Α., Farkhondeh, T., İlgün, S., Pourbagher‐Shahri, A. M., & Samarghandian, S. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1923479 · Cited by 41
Derungs, R., Camici, G. G., Spescha, R. D., Welt, T., Tackenberg, C., Späni, C. B., Wirth, F., Grimm, A., Eckert, A., Nitsch, R. M., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.112 · Cited by 39
Battaglia, C. R., Cursano, S., Calzia, E., Catanese, A., & Boeckers, T. M. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03204-3 · Cited by 38
Interactions between amyloid, amyloid precursor protein, and mitochondria
Wilkins, H. (2023) · Biochemical Society Transactions · doi:10.1042/bst20220518 · Cited by 37
mtDNA Maintenance and Alterations in the Pathogenesis of Neurodegenerative Diseases
Shang, D., Huang, M., Wang, B., Yan, X., Wu, Z., & Zhang, X. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220810114644 · Cited by 44
Alzheimer’s disease: diagnostics, prognostics and the road to prevention
Grossman, I., Lutz, M. W., Crenshaw, D. G., Saunders, A. M., Burns, D. K., & Roses, A. D. (2010) · EPMA Journal · doi:10.1007/s13167-010-0024-3 · Cited by 37
Biomarkers: Our Path Towards a Cure for Alzheimer Disease
Tarawneh, R. M. (2020) · Biomarker Insights · doi:10.1177/1177271920976367 · Cited by 42
Association of Omi/HtrA2 with γ-secretase in mitochondria
Behbahani, H., Pavlov, P. F., Wiehager, B., Nishimura, T., Winblad, B. G., & Ankarcrona, M. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.08.004 · Cited by 37
Bar‐Am, O., Amit, T., Youdim, M. B. H., & Weinreb, O. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-015-1395-3 · Cited by 37
Wu, Z., Zhu, Y., Cao, X., Sun, S., & Zhao, B. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8675-z · Cited by 36
Mohamed, T. M., Youssef, M. A. M., Bakry, A. A., & El-Keiy, M. M. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00639-7 · Cited by 37
Wilkins, H., Troutwine, B., Menta, B. W., Manley, S., Strope, T., Lysaker, C., & Swerdlow, R. H. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215280 · Cited by 38
Ma, X., Yu, J., Wang, W., Wang, H.-F., Liu, Q., Zhang, W., & Tan, L. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8217-7 · Cited by 35
Schuh, R. A., Jackson, K. C., Schlappal, A. E., Spangenburg, E. E., Ward, C. W., Park, J. H., Dugger, N. V., Shi, G., & Fishman, P. S. (2014) · BMC Neuroscience · doi:10.1186/1471-2202-15-24 · Cited by 36
The Role of Oxidative Stress in Neurodegenerative Diseases
Ksiazek-Winiarek, D. J., & Glabinski, A. R. (2014) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4939-0440-2_8 · Cited by 36
Bioenergetics and metabolism: a bench to bedside perspective
Swerdlow, R. H. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13509 · Cited by 35
New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders
Wilkins, H., & Morris, J. K. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612822666161230144517 · Cited by 34
Schaefer, P., von Einem, B., Walther, P., Calzia, E., & Arnim, C. A. F. V. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168157 · Cited by 34
Heinemeyer, T., Stemmet, M., Bardien, S., & Neethling, A. (2018) · DNA and Cell Biology · doi:10.1089/dna.2018.4292 · Cited by 35
The vexing complexity of the amyloidogenic pathway
Castro, M., Hadziselimovic, A., & Sanders, C. R. (2019) · Protein Science · doi:10.1002/pro.3606 · Cited by 40
Needs, H. I., Protasoni, M., Henley, J. M., Prudent, J., Collinson, I. R., & Pereira, G. C. (2021) · Life · doi:10.3390/life11050432 · Cited by 32
Intracellular Aβ42 Aggregation Leads to Cellular Thermogenesis
Chung, C. W., Stephens, A. D., Konno, T., Ward, E., Avezov, E., Kaminski, C. F., Hassanali, A. A., & Schierle, G. S. K. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c03599 · Cited by 35
Pfeiffer, N. V., Dirndorfer, D., Lang, S., Resenberger, U. K., Restelli, L. M., Hemion, C., Miesbauer, M., Frank, S., Neutzner, A., Zimmermann, R., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.46 · Cited by 35
Amyloid precursor protein and mitochondria
Strope, T. A., & Wilkins, H. (2022) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2022.102651 · Cited by 37
The Mitochondrial Secret(ase) of Alzheimer's Disease
Young, K. J., & Bennett, J. P. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100360 · Cited by 34
Mitochondrial β-amyloid in Alzheimer's disease
Borger, E., Aitken, L., Muirhead, K. E. A., Allen, Z., Ainge, J. A., Conway, S. J., & Gunn‐Moore, F. J. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390868 · Cited by 33
Genetic Variants and Oxidative Stress in Alzheimer’s Disease
Kowalska, M., Wize, K., Prendecki, M., Lianeri, M., Kozubski, W. P., & Dorszewska, J. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200224121447 · Cited by 34
NIPSNAP protein family emerges as a sensor of mitochondrial health
Fathi, E., Yarbro, J. M., & Homayouni, R. (2021) · BioEssays · doi:10.1002/bies.202100014 · Cited by 35
Liang, X., Liu, C., Liu, K., Cong, L., Wang, Y., Liu, R., Fa, W., Tian, N., Cheng, Y., Wang, N., et al. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.12.013 · Cited by 33
Intramitochondrial proteostasis is directly coupled to α-synuclein and amyloid β1-42 pathologies
Lautenschläger, J., Wagner-Valladolid, S., Stephens, A. D., Fernández‐Villegas, A., Hockings, C., Mishra, A., Manton, J. D., Fantham, M., Lü, M., Rees, E. J., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011650 · Cited by 36
Atlante, A., & Valenti, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115951 · Cited by 33
Alzheimer disease as a vascular disorder: Where do mitochondria fit?
Correia, S. C., Santos, R. X., Cardoso, S., Carvalho, C., Candeias, E., Duarte, A. I., Plácido, A. I., Santos, M. S., & Moreira, P. I. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.07.006 · Cited by 32
Metal attenuating therapies in neurodegenerative disease
Mot, A. I., Wedd, A. G., Sinclair, L., Brown, D. R., Collins, S. J., & Brazier, M. W. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.170 · Cited by 32
Pahnke, J., Fröhlich, C., Krohn, M., Schumacher, T., & Paarmann, K. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.08.007 · Cited by 35
Genetic Variability in Molecular Pathways Implicated in Alzheimer's Disease: A Comprehensive Review
Vogrinc, D., Goričar, K., & Dolžan, V. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.646901 · Cited by 32
Boosting mitochondrial health to counteract neurodegeneration
Burtscher, J., Romani, M., Bernardo, G., Popa, T., Ziviani, E., Hummel, F. C., Sorrentino, V., & Millet, G. P. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102289 · Cited by 36
Bhole, R. P., Chikhale, R. V., & Rathi, K. M. (2023) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2023.11.003 · Cited by 34
Ferencz, B., Karlsson, S., & Kalpouzos, G. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/421452 · Cited by 35
Wan, L., Nie, G., Zhang, J., & Zhao, B. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111169 · Cited by 32
Neuronopathic Gaucher disease: Beyond lysosomal dysfunction
Arévalo, N. B., Lamaizon, C. M., Cavieres, V. A., Burgos, P. V., Alvarez, A. R., Yañez, M. J., & Zanlungo, S. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.934820 · Cited by 31
OMA1 protease eliminates arrested protein import intermediates upon mitochondrial depolarization
Krakowczyk, M., Lenkiewicz, A. M., Sitarz, T., Malińska, D., Borrero-Landazabal, M. A., Mussulini, B. H. M., Linke, V., Szczepankiewicz, A. A., Biazik, J. M., Wydrych, A., et al. (2024) · The Journal of Cell Biology · doi:10.1083/jcb.202306051 · Cited by 37
Yin, P., Tu, Z., Yin, A., Zhao, T., Yan, S., Guo, X., Chang, R., Zhang, L., Hong, Y., Huang, X., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu544 · Cited by 31
Mitochondrial diseases caused by dysfunctional mitochondrial protein import
Jackson, T. D., Palmer, C. S., & Stojanovski, D. (2018) · Biochemical Society Transactions · doi:10.1042/bst20180239 · Cited by 31
The role of cell type-specific mitochondrial dysfunction in the pathogenesis of Alzheimer's disease
Kim, D., & Mook‐Jung, I. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.12.282 · Cited by 31
Kang, N., Luan, Y., Jiang, Y., Cheng, W., Liu, Y., Su, Z., Liu, Y., & Tan, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.878631 · Cited by 31
Atamna, H. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9246-2 · Cited by 31
Blesa, J. R., Solano, A., Briones, P., Prieto-Ruiz, J. Á., Hernández-Yago, J., & Coria, F. (2007) · NeuroMolecular Medicine · doi:10.1007/s12017-007-8000-3 · Cited by 31
Pająk, B., Kania, E., & Orzechowski, A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1805304 · Cited by 31
Corrêa-Velloso, J. C., Gonçalves, M. C., Naaldijk, Y., Oliveira‐Giacomelli, Á., Pillat, M. M., & Ulrich, H. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.033 · Cited by 31
Fleck, D., Phu, L., Verschueren, E., Hinkle, T. B., Reichelt, M., Bhangale, T., Haley, B., Wang, Y., Graham, R., Kirkpatrick, D. S., et al. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0116-19.2019 · Cited by 31
The Journey of Mitochondrial Protein Import and the Roadmap to Follow
Haastrup, M. O., Vikramdeo, K. S., Singh, S., Singh, A. P., & Dasgupta, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032479 · Cited by 33
Mitochondrial nanomedicine: Subcellular organelle-specific delivery of molecular medicines
Milane, L. S., Dolare, S., Jahan, T., & Amiji, M. M. (2021) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2021.102422 · Cited by 31
Biogenesis of mitochondrial outer membrane proteins, problems and diseases
Ellenrieder, L., Mårtensson, C. U., & Becker, T. (2015) · Biological Chemistry · doi:10.1515/hsz-2015-0170 · Cited by 30
Beta-Amyloid Instigates Dysfunction of Mitochondria in Cardiac Cells
Jang, S., Chapa‐Dubocq, X. R., Parodi‐Rullán, R. M., Fossati, S., & Javadov, S. A. (2022) · Cells · doi:10.3390/cells11030373 · Cited by 30
Relationship Between Genetic Risk Factors and Markers for Alzheimer’s Disease Pathology
Elias-Sonnenschein, L. S., Bertram, L., & Visser, P. J. (2012) · Biomarkers in Medicine · doi:10.2217/bmm.12.56 · Cited by 28
Mitochondria in Alzheimer’s Disease and Diabetes-Associated Neurodegeneration: License to Heal!
Cardoso, S., Correia, S. C., Carvalho, C., & Moreira, P. I. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_3 · Cited by 29
Mitochondrial Deficits With Neural and Social Damage in Early-Stage Alzheimer’s Disease Model Mice
Misrani, A., Tabassum, S., Huo, Q., Tabassum, S., Jiang, J., Ahmed, A., Chen, X., Zhou, J., Zhang, J., Liu, S., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.748388 · Cited by 29
The amyloid state of proteins: A boon or bane?
Hassan, M. N., Nabi, F., Khan, A. N., Hussain, M. S., Siddiqui, W. A., Uversky, V. N., & Khan, R. H. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.01.115 · Cited by 30
Anandatheerthavarada, H. K., & Devi, L. (2007) · Reviews in the Neurosciences · doi:10.1515/revneuro.2007.18.5.343 · Cited by 28
Neurodegenerative disorders, metabolic icebergs, and mitohormesis
Phillips, M. C. L., & Picard, M. A. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00435-8 · Cited by 31
MicroRNA‑4722‑5p and microRNA‑615‑3p serve as potential biomarkers for Alzheimer's disease
Liu, Y., Xu, Y., & Yu, M. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11166 · Cited by 29
From the Structural and (Dys)Function of ATP Synthase to Deficiency in Age-Related Diseases
Garone, C., Pietra, A., & Nesci, S. (2022) · Life · doi:10.3390/life12030401 · Cited by 29
Mitochondrial mechanisms in Alzheimer’s disease: Quest for therapeutics
Kalani, K., Chaturvedi, P., Chaturvedi, P., Verma, V. K., Lal, N., Awasthi, S. K., & Kalani, A. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103547 · Cited by 28
Peixoto, P. M. V., Dejean, L. M., & Kinnally, K. W. (2011) · Mitochondrion · doi:10.1016/j.mito.2011.03.003 · Cited by 29
Shen, R., Ardianto, C., Celia, C., Sidharta, V. M., Sasmita, P. K., Satriotomo, I., & Turana, Y. (2023) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2023-0012 · Cited by 31
Does photobiomodulation alter mitochondrial dynamics?
Trajano, L. A. D. S. N., Siqueira, P. B., Rodrigues, M. M. D. S., Pires, B. R. B., da Fonseca, A. D. S., & Mencalha, A. L. (2024) · Photochemistry and Photobiology · doi:10.1111/php.13963 · Cited by 27
The organellar peptidasome, PreP: A journey from Arabidopsis to Alzheimer's disease
Glaser, E. G., & Alikhani, N. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2009.12.016 · Cited by 28
Du, Y.-H., Yang, R., Wang, Q., Wang, L., Liang, L., Zhu, L., Sun, Y., & Cai, M. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.670220 · Cited by 27
Pathogenic role of mitochondrial amyloid-β peptide
Chen, J. X., & Yan, S. D. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.11.1517 · Cited by 26
Gelsolin as therapeutic target in Alzheimer's disease
Carro, E. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.488222 · Cited by 27
Lin, R., Zhang, Y., Yan, D., Liao, X., Gong, G., Hu, J., Fu, Y., & Cai, W. (2015) · Journal of Human Genetics · doi:10.1038/jhg.2015.150 · Cited by 28
Alzheimer's disease: the role of mitochondrial dysfunction and potential new therapies
Hawking, Z. L. (2016) · Bioscience Horizons The International Journal of Student Research · doi:10.1093/biohorizons/hzw014 · Cited by 29
Montagna, E., Crux, S., Luckner, M., Herber, J., Colombo, A. V., Marinković, P., Tahirović, S., Lichtenthaler, S. F., Wanner, G., Müller, U., et al. (2019) · Glia · doi:10.1002/glia.23584 · Cited by 27
Livner, Å., Laukka, E. J., Karlsson, S., & Bäckman, L. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.02.377 · Cited by 27
Tummala, H., Li, X., & Homayouni, R. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07248.x · Cited by 26
Li, L., Du, J., Zou, L., Xia, H., Wu, T., Kim, Y.-H., & Lee, Y. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1623-0 · Cited by 26
Wang, Y., Wu, F., Pan, H., Zheng, W., Feng, C. T., Wang, Y., Deng, Z., Wang, L., Luo, J., & Chen, S. (2016) · Scientific Reports · doi:10.1038/srep22244 · Cited by 26
The transcriptional landscape of Alzheimer’s disease and its association with Wnt signaling pathway
Martínez, M., & Inestrosa, N. C. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.029 · Cited by 26
Panahzadeh, F., Mirnasuri, R., & Rahmati, M. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114871 · Cited by 26
The key roles of organelles and ferroptosis in Alzheimerʼs disease
Long, H., Cheng, Y., Zhou, Z., Luo, H., Wen, D., & Gao, L. (2022) · Journal of Neuroscience Research · doi:10.1002/jnr.25033 · Cited by 28
Goemans, C. G., Boya, P., Skirrow, C. J., & Tolkovsky, A. M. (2008) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402290 · Cited by 26
Drug Development in Alzheimer’s Disease: The Contribution of PET and SPECT
Declercq, L., Vandenberghe, R. R., Laere, K. V., Verbruggen, A., & Bormans, G. M. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00088 · Cited by 27
Srivastava, S., Vishwanathan, V., Birje, A., Sinha, D., & D’Silva, P. (2019) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2020.1718062 · Cited by 25
González-Chapa, J. A., Macêdo, M. B., & Lood, C. (2023) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10493 · Cited by 25
Edaravone injection reverses learning and memory deficits in a rat model of vascular dementia
Xu, L., Fen, L., Li, W., Qin, L., Yao, Y., Ge, X., Yu, Q.-K., Liang, X., Zhao, D., Li, X., et al. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmw116 · Cited by 24
Greene, L. E., Lincoln, R., & Cosa, G. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.04.006 · Cited by 26
Impact of Genetic Risk Factors for Alzheimer’s Disease on Brain Glucose Metabolism
Cho, S., Lee, H., & Seo, J. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02297-x · Cited by 25
Common aspects between glaucoma and brain neurodegeneration
Saccà, S. C., Paluan, F., Gandolfi, S., Manni, G., Cutolo, C. A., & Izzotti, A. (2020) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2020.108323 · Cited by 25
Targeting Mitophagy in Alzheimer’s Disease
Jayatunga, D. P. W., Hone, E., Bharadwaj, P., Garg, M. L., Verdile, G., Guillemin, G. J., & Martins, R. N. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191258 · Cited by 25
Domínguez-Prieto, M., Velasco, A. L., Vega, L., Tabernero, A., & Medina, J. M. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160346 · Cited by 24
Singh, A., Tiwari, S., & Singh, S. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06662-1 · Cited by 23
Mitochondrial dysfunction and Alzheimer’s disease: pathogenesis of mitochondrial transfer
Wei, Y., Du, X., Guo, H., Han, J., & Liu, M. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1517965 · Cited by 23
Mitochondrial Protein Import Dysfunction in Pathogenesis of Neurodegenerative Diseases
Goyal, S., & Chaturvedi, R. K. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02200-0 · Cited by 25
Mini review: Mitochondrial dysfunction in Alzheimer's disease: Therapeutic implications of lithium
Singulani, M. P., Paula, V. J. R. D., & Forlenza, O. V. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136078 · Cited by 23
Varshini, M. S., Krishnamurthy, P. T., Shaji, N., Mani, L., & Balasubramanian, S. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24933 · Cited by 24
Is Drp1 a link between mitochondrial dysfunction and inflammation in Alzheimer’s disease?
Sbai, O., Bazzani, V., Tapaswi, S., McHale, J., Vascotto, C., & Perrone, L. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1166879 · Cited by 24
Mitochondrial Regulatory Pathways in the Pathogenesis of Alzheimer’s Disease
Adiele, R. C., & Adiele, C. A. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150967 · Cited by 23
Metadata
- Authors
- Devi, L., Prabhu, B. M., Galati, D. F., Avadhani, N. G., & Anandatheerthavarada, H. K.
- Affiliations
- University of Pennsylvania (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2006-08-30
- Volume
- 26
- Issue
- 35
- Pages
- 9057-9068
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6675337
- OpenAlex
- W2076241970
- Cited by
- 792
- References
- 62
- Citations by year
- 2026: 21 · 2025: 21 · 2024: 36 · 2023: 47 · 2022: 53 · 2021: 60 · 2020: 50 · 2019: 37 · 2018: 44 · 2017: 39 · 2016: 36 · 2015: 35 · 2014: 34 · 2013: 40 · 2012: 50
- FWCI
- 19.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (R01AG021920, AG 021920)
- National Institute of General Medical Sciences (GM-49683, R01GM049683)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- amyloid precursor protein, Alzheimer's disease, mitochondrial dysfunction, Tom40, Tim23, cytochrome c oxidase, hydrogen peroxide, neuronal cell types
- MeSH terms
- Alzheimer Disease, Apolipoproteins E, Biological Transport, Brain, Cadaver, Electron Transport Complex IV, Glycosylation, Humans, Hydrogen Peroxide, Mitochondria, Neurons, Tissue Distribution, Case-Control Studies, Amyloid beta-Protein Precursor, Mitochondrial Proteins, Mitochondrial Membrane Transport Proteins, Mitochondrial Membranes, Apolipoprotein E3, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
